BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

223 related articles for article (PubMed ID: 10343351)

  • 1. The bioavailability of non-nutrient plant factors: dietary flavonoids and phyto-oestrogens.
    Wiseman H
    Proc Nutr Soc; 1999 Feb; 58(1):139-46. PubMed ID: 10343351
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bioavailability of phyto-oestrogens.
    Rowland I; Faughnan M; Hoey L; Wähälä K; Williamson G; Cassidy A
    Br J Nutr; 2003 Jun; 89 Suppl 1():S45-58. PubMed ID: 12725656
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Isoflavone phytoestrogens consumed in soy decrease F(2)-isoprostane concentrations and increase resistance of low-density lipoprotein to oxidation in humans.
    Wiseman H; O'Reilly JD; Adlercreutz H; Mallet AI; Bowey EA; Rowland IR; Sanders TA
    Am J Clin Nutr; 2000 Aug; 72(2):395-400. PubMed ID: 10919933
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phyto-oestrogens and cardiovascular disease risk.
    van der Schouw YT; de Kleijn MJ; Peeters PH; Grobbee DE
    Nutr Metab Cardiovasc Dis; 2000 Jun; 10(3):154-67. PubMed ID: 11006924
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bioavailability of pure isoflavones in healthy humans and analysis of commercial soy isoflavone supplements.
    Setchell KD; Brown NM; Desai P; Zimmer-Nechemias L; Wolfe BE; Brashear WT; Kirschner AS; Cassidy A; Heubi JE
    J Nutr; 2001 Apr; 131(4 Suppl):1362S-75S. PubMed ID: 11285356
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phyto-oestrogens: a potential role in the prevention of CHD?
    Cassidy A; Griffin B
    Proc Nutr Soc; 1999 Feb; 58(1):193-9. PubMed ID: 10343357
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The therapeutic potential of phytoestrogens.
    Wiseman H
    Expert Opin Investig Drugs; 2000 Aug; 9(8):1829-40. PubMed ID: 11060780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Case-control study of phyto-oestrogens and breast cancer.
    Ingram D; Sanders K; Kolybaba M; Lopez D
    Lancet; 1997 Oct; 350(9083):990-4. PubMed ID: 9329514
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relationships of urinary phyto-oestrogen excretion to BMD in postmenopausal women.
    Kim MK; Chung BC; Yu VY; Nam JH; Lee HC; Huh KB; Lim SK
    Clin Endocrinol (Oxf); 2002 Mar; 56(3):321-8. PubMed ID: 11940043
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of isoflavones among dietary intake, plasma concentration and urinary excretion for accurate estimation of phytoestrogen intake.
    Arai Y; Uehara M; Sato Y; Kimira M; Eboshida A; Adlercreutz H; Watanabe S
    J Epidemiol; 2000 Mar; 10(2):127-35. PubMed ID: 10778038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Phyto-oestrogens, their mechanism of action: current evidence for a role in breast and prostate cancer.
    Magee PJ; Rowland IR
    Br J Nutr; 2004 Apr; 91(4):513-31. PubMed ID: 15035679
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary soy-derived isoflavone phytoestrogens. Could they have a role in coronary heart disease prevention?
    Tikkanen MJ; Adlercreutz H
    Biochem Pharmacol; 2000 Jul; 60(1):1-5. PubMed ID: 10807939
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Food sources of phyto-oestrogens and their precursors in Europe.
    Fletcher RJ
    Br J Nutr; 2003 Jun; 89 Suppl 1():S39-43. PubMed ID: 12725655
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparative assessment of endocrine modulators with oestrogenic activity: I. Definition of a hygiene-based margin of safety (HBMOS) for xeno-oestrogens against the background of European developments.
    Bolt HM; Janning P; Michna H; Degen GH
    Arch Toxicol; 2001 Jan; 74(11):649-62. PubMed ID: 11218041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Phyto-oestrogens: where are we now?
    Bingham SA; Atkinson C; Liggins J; Bluck L; Coward A
    Br J Nutr; 1998 May; 79(5):393-406. PubMed ID: 9682657
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Potential risks and benefits of phytoestrogen-rich diets.
    Cassidy A
    Int J Vitam Nutr Res; 2003 Mar; 73(2):120-6. PubMed ID: 12747219
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of the dietary flavonoid quercetin on the cardioprotective antioxidant action of oestrogen and phytoestrogens.
    Wiseman H; O'Reilly J
    Biochem Soc Trans; 1997 Feb; 25(1):108S. PubMed ID: 9057006
    [No Abstract]   [Full Text] [Related]  

  • 18. Xeno-oestrogens and phyto-oestrogens induce the synthesis of leukaemia inhibitory factor by human and bovine oviduct cells.
    Reinhart KC; Dubey RK; Keller PJ; Lauper U; Rosselli M
    Mol Hum Reprod; 1999 Oct; 5(10):899-907. PubMed ID: 10508216
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of dietary phyto-oestrogens in the protection against cancer and heart disease.
    Wiseman H
    Biochem Soc Trans; 1996 Aug; 24(3):795-800. PubMed ID: 8878850
    [No Abstract]   [Full Text] [Related]  

  • 20. The phytoestrogen equol increases nitric oxide availability by inhibiting superoxide production: an antioxidant mechanism for cell-mediated LDL modification.
    Hwang J; Wang J; Morazzoni P; Hodis HN; Sevanian A
    Free Radic Biol Med; 2003 May; 34(10):1271-82. PubMed ID: 12726915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.